White Paper

Developability Assessment Of Small Molecules

Scientist Analyzing Test Tube

Developability assessment or preformulation studies of small molecule is an important part of the drug discovery process leading to selection of New Chemical Entities (NCEs) for clinical studies. These studies include physicochemical and biopharmaceutical characterization, development of suitable formulations, physical form for pharmacokinetic, efficacy and toxicity studies and providing formulation strategy for Phase I clinical studies.

The overall objective of preformulation testing is to gather enough data in order to develop a chemically stable and therapeutically effective drug product that can be commercially produced at large scale.

Download this white paper to gain a better understanding into why we need developability assessment as well as its processes.

VIEW THE WHITE PAPER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: